DAWN – Day One Biopharmaceuticals, Inc.
DAWN
$7.22Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $731,833,600.00
EPSttm : -0.65
Day One Biopharmaceuticals, Inc
$7.22
Float Short %
24.68
Margin Of Safety %
Put/Call OI Ratio
0.26
EPS Next Q Diff
0.02
EPS Last/This Y
-0.34
EPS This/Next Y
0.5
Price
6.95
Target Price
28
Analyst Recom
1.22
Performance Q
-23.63
Relative Volume
0.58
Beta
-1.3
Ticker: DAWN
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-05-07 | DAWN | 6.3 | 0.41 | 0.10 | 5102 |
2025-05-08 | DAWN | 6.74 | 0.42 | 0.17 | 5084 |
2025-05-09 | DAWN | 6.45 | 0.41 | 999.99 | 5155 |
2025-05-12 | DAWN | 6.58 | 0.41 | 0.00 | 5155 |
2025-05-13 | DAWN | 6.34 | 0.30 | 0.02 | 4796 |
2025-05-14 | DAWN | 6.18 | 0.28 | 0.28 | 4969 |
2025-05-15 | DAWN | 6.16 | 0.28 | 0.07 | 5015 |
2025-05-16 | DAWN | 6.26 | 0.27 | 0.00 | 5120 |
2025-05-19 | DAWN | 6.47 | 0.27 | 0.00 | 4789 |
2025-05-20 | DAWN | 6.58 | 0.27 | 0.00 | 4874 |
2025-05-21 | DAWN | 6.3 | 0.27 | 999.99 | 4895 |
2025-05-22 | DAWN | 6.27 | 0.27 | 1.92 | 4905 |
2025-05-23 | DAWN | 6.27 | 0.27 | 0.07 | 4938 |
2025-05-27 | DAWN | 6.31 | 0.27 | 0.94 | 5052 |
2025-05-28 | DAWN | 6.3 | 0.27 | 0.00 | 5074 |
2025-05-29 | DAWN | 6.48 | 0.26 | 0.00 | 5173 |
2025-05-30 | DAWN | 6.39 | 0.26 | 999.99 | 5181 |
2025-06-02 | DAWN | 7.01 | 0.26 | 0.00 | 5186 |
2025-06-03 | DAWN | 6.96 | 0.26 | 0.10 | 5197 |
2025-06-04 | DAWN | 6.94 | 0.26 | 0.40 | 5318 |
2025-06-05 | DAWN | 6.94 | 0.26 | 0.04 | 5330 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-05-07 | DAWN | 6.30 | 39.0 | - | -1.61 |
2025-05-08 | DAWN | 6.74 | -630.7 | - | -1.50 |
2025-05-09 | DAWN | 6.45 | -630.7 | - | -1.34 |
2025-05-12 | DAWN | 6.58 | -630.7 | - | -1.34 |
2025-05-13 | DAWN | 6.33 | -583.4 | - | -1.34 |
2025-05-14 | DAWN | 6.20 | -583.4 | - | -1.34 |
2025-05-15 | DAWN | 6.16 | -583.4 | - | -1.34 |
2025-05-16 | DAWN | 6.26 | -591.0 | - | -1.36 |
2025-05-19 | DAWN | 6.48 | -591.0 | - | -1.36 |
2025-05-20 | DAWN | 6.57 | -591.0 | - | -1.36 |
2025-05-21 | DAWN | 6.30 | -591.0 | - | -1.36 |
2025-05-22 | DAWN | 6.28 | -591.0 | - | -1.36 |
2025-05-23 | DAWN | 6.28 | -591.0 | - | -1.36 |
2025-05-27 | DAWN | 6.30 | -591.0 | - | -1.36 |
2025-05-28 | DAWN | 6.31 | -591.0 | - | -1.36 |
2025-05-29 | DAWN | 6.48 | -591.0 | - | -1.36 |
2025-05-30 | DAWN | 6.38 | -591.0 | - | -1.36 |
2025-06-02 | DAWN | 7.01 | -591.0 | - | -1.36 |
2025-06-03 | DAWN | 6.98 | -591.0 | - | -1.36 |
2025-06-04 | DAWN | 6.93 | -591.0 | - | -1.36 |
2025-06-05 | DAWN | 6.95 | -591.0 | - | -1.36 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-05-07 | DAWN | -0.40 | -0.33 | 24.51 |
2025-05-08 | DAWN | -0.40 | -0.33 | 24.51 |
2025-05-09 | DAWN | -0.36 | -0.33 | 24.51 |
2025-05-12 | DAWN | -0.36 | 0.05 | 23.83 |
2025-05-13 | DAWN | -0.26 | 0.05 | 23.83 |
2025-05-14 | DAWN | -0.26 | 0.05 | 23.83 |
2025-05-15 | DAWN | -0.26 | 0.05 | 23.88 |
2025-05-16 | DAWN | -0.26 | 0.05 | 23.88 |
2025-05-19 | DAWN | -0.26 | -5.07 | 23.84 |
2025-05-20 | DAWN | -0.29 | -5.07 | 23.69 |
2025-05-21 | DAWN | -0.29 | -5.07 | 23.69 |
2025-05-22 | DAWN | -0.29 | -5.07 | 23.69 |
2025-05-23 | DAWN | -0.29 | -5.07 | 23.69 |
2025-05-27 | DAWN | -0.29 | 0.42 | 23.71 |
2025-05-28 | DAWN | -0.29 | 0.42 | 24.68 |
2025-05-29 | DAWN | -0.29 | 0.42 | 24.68 |
2025-05-30 | DAWN | -0.29 | 0.42 | 24.68 |
2025-06-02 | DAWN | -0.29 | 0.70 | 24.68 |
2025-06-03 | DAWN | -0.29 | 0.70 | 24.68 |
2025-06-04 | DAWN | -0.29 | 0.70 | 24.68 |
2025-06-05 | DAWN | -0.29 | 0.70 | 24.68 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.35
Avg. EPS Est. Next Quarter
-0.33
Insider Transactions
-0.29
Institutional Transactions
0.7
Beta
-1.3
Average Sales Estimate Current Quarter
35
Average Sales Estimate Next Quarter
40
Fair Value
Quality Score
46
Growth Score
25
Sentiment Score
35
Actual DrawDown %
75.8
Max Drawdown 5-Year %
Target Price
28
P/E
Forward P/E
PEG
P/S
4.35
P/B
1.47
P/Free Cash Flow
EPS
-0.67
Average EPS Est. Cur. Y
-1.36
EPS Next Y. (Est.)
-0.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.66
Relative Volume
0.58
Return on Equity vs Sector %
-38.4
Return on Equity vs Industry %
-20.6
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.06
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading